Search by Drug Name or NDC

NDC 68254-5006-05 Tacrolimus 5 mg/1 Details

Tacrolimus 5 mg/1

Tacrolimus is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CONCORD BIOTECH LIMITED. The primary component is TACROLIMUS.

MedlinePlus Drug Summary

Tacrolimus (Astagraf XL, Envarsus XR, Prograf) is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received a kidney transplant. Tacrolimus (Prograf) is also used along with other medications to prevent rejection in people who have received a liver, lung, or heart transplant. Tacrolimus is in a class of medications called immunosupressants. It works by decreasing the activity of the immune system to prevent it from attacking the transplanted organ.

Related Packages: 68254-5006-05
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tacrolimus

Product Information

NDC	68254-5006
Product ID	68254-5006_76ffdfc1-7f00-49da-9578-5352593b4830
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Tacrolimus
Proprietary Name Suffix	n/a
Non-Proprietary Name	Tacrolimus
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	5
Active Ingredient Units	mg/1
Substance Name	TACROLIMUS
Labeler Name	CONCORD BIOTECH LIMITED
Pharmaceutical Class	Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA213112
Listing Certified Through	2024-12-31

Package

NDC 68254-5006-05 (68254500605)

Pricing Information	N/A
NDC Package Code	68254-5006-5
Billing NDC	68254500605
Package	30 CAPSULE in 1 BOTTLE (68254-5006-5)
Marketing Start Date	2020-11-23
NDC Exclude Flag	N